跳至主要内容
临床试验/NCT00701623
NCT00701623撤回2 期

Clinical Efficacy of Product Alimax ® (Sodic Heparin) in Treatment of Burns: Comparative Study of Raw Materials Between Two Suppliers

Azidus Brasil1 个研究点 分布在 1 个国家开始时间: 2008年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
撤回
发起方
Azidus Brasil
试验地点
1
主要终点
Primary: immediate decrease in pain. Secondary: analgesic request for 10 minutes after application of heparin, signs of intolerance and adverse events.

研究概览

简要总结

Burns are injuries caused by agents thermal, chemical, electrical or radioactive who act in the tissue lining of the human body and may partially or totally destroy the skin and its annexes, to the deeper layers, as subcutaneous tissue, muscles, tendons and bones .

Studies show that topical heparin has, in addition to the already known anticoagulant activity, anti-inflammatory properties, analgesic, and neoangiogenic, stimulating blood flow and increasing the repair of the fabric as well as the restoration of collagen and reepiteliztion. Moreover, the use of heparin reduces the need for painful medical procedures, as debridations, surgeries and transplants The intention of this work is to verify the effectiveness and safety of sodium heparin in the treatment of burns of the skin.

详细描述

Patients with burns that come to the emergency room will be informed about the

Inclusion Criteria

  • Patients aged above 12 years who have suffered thermal burns of 2nd degree burns or mixed 2 and 3 degrees in up to 10% of body surface and indication of outpatient treatment.

Exclusion Criteria

  • Area burned more than 10% of body surface
  • the presence of the 3 rd degree burns
  • burns in the face or genitals
  • burns in poly-traumatized
  • respiratory injury
  • disorders of coagulation
  • thrombocytopenia
  • erosive gastro cases
  • clinically relevant bleeding
  • hypersensitivity to anticoagulants
  • liver disease
  • nephropathy
  • diabetes
  • 35
  • serious allergy
  • descontrole emotional
  • pregnancy
  • anemia

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged above 12 years who have suffered thermal burns of 2nd degree burns or mixed 2 and 3 degrees in up to 10% of body surface and indication of outpatient treatment.

排除标准

  • Area burned more than 10% of body surface
  • the presence of the 3 rd degree burns
  • burns in the face or genitals
  • burns in poly-traumatized
  • respiratory injury
  • disorders of coagulation
  • thrombocytopenia
  • erosive gastro cases
  • clinically relevant bleeding
  • hypersensitivity to anticoagulants
  • liver disease
  • nephropathy
  • serious allergy
  • descontrole emotional
  • pregnancy

研究组 & 干预措施

1

Experimental

patients treated with heparin

干预措施: heparin (Drug)

2

Experimental

Patients treated with heparin

干预措施: heparin (Drug)

3

Active Comparator

patients treated with folder water directly on the injured area

干预措施: folder water (Drug)

结局指标

主要结局

Primary: immediate decrease in pain. Secondary: analgesic request for 10 minutes after application of heparin, signs of intolerance and adverse events.

时间窗: healing

次要结局

未报告次要终点

研究者

发起方
Azidus Brasil
申办方类型
Industry
责任方
Principal Investigator
主要研究者

Azidus Brasil

Principal Investigator Dr. Alexandre Frederico

Azidus Brasil

研究点 (1)

Loading locations...

相似试验

Sodic Heparin Effectiveness of the Treatment of Burns | 临床试验